Table 1.

Patient demographics by weighted averages

Adverse-risk modelIntermediate-risk model
VariableAza-venICVariableAza-venIC
Age, y 66.9 58.3 Age, y 72.4 55.2 
Male (%) 0.517 0.528 Male (%) 0.57 0.486 
Female (%) 0.483 0.472 Female (%) 0.43 0.514 
Bone marrow blasts (%) 0.502 0.66 Bone marrow blasts (%) 0.5 0.809 
Secondary AML (%) 0.459 0.082 Secondary AML (%) 0.3 0.09 
Treatment-related AML (%) 0.212 0.07 Treatment-related AML (%) 0.264 0.06 
Adverse-risk modelIntermediate-risk model
VariableAza-venICVariableAza-venIC
Age, y 66.9 58.3 Age, y 72.4 55.2 
Male (%) 0.517 0.528 Male (%) 0.57 0.486 
Female (%) 0.483 0.472 Female (%) 0.43 0.514 
Bone marrow blasts (%) 0.502 0.66 Bone marrow blasts (%) 0.5 0.809 
Secondary AML (%) 0.459 0.082 Secondary AML (%) 0.3 0.09 
Treatment-related AML (%) 0.212 0.07 Treatment-related AML (%) 0.264 0.06 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal